Related Experiment Video
Updated: Jul 14, 2026
08:18
Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
Hepatocellular carcinoma-associated gene 2 interacts with MAD2L2
1State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai 200433, China.
Molecular and Cellular Biochemistry
|June 2, 2007
Summary
Hepatocellular carcinoma-associated gene 2 (HCCA2) interacts with MAD2L2, inhibiting cell proliferation and suggesting a role in cell cycle regulation for liver cancer.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Hepatocellular carcinoma-associated gene 2 (HCCA2) was initially identified as a hepatocellular carcinoma (HCC)-specific protein.
- A long splice variant of HCCA2 functions as a co-activator for the transcription factor Yin Yang 1 (YY1).
Purpose of the Study:
- To investigate the role of HCCA2 in HCC genesis and progression.
- To identify novel HCCA2-interacting proteins.
Main Methods:
- Screening of a human fetal liver cDNA library.
- In vitro and in vivo binding assays to confirm protein interactions.
- Mapping of interaction domains using sequential deletion.
- Confocal microscopy to assess protein colocalization.
- Cell cycle analysis following HCCA2 overexpression.
Main Results:
- A novel HCCA2-interacting protein, MAD2 mitotic arrest deficient-like 2 (MAD2L2), was identified.
- The interaction between HCCA2 and MAD2L2 was confirmed and localized to the N-terminus of HCCA2.
- HCCA2 and MAD2L2 were found to colocalize in the nucleus of HeLa cells.
- Overexpression of HCCA2 induced cell cycle arrest at the G0/G1 phase, inhibiting cell proliferation.
Conclusions:
- HCCA2 interacts with MAD2L2, suggesting a potential functional relationship in cellular processes.
- HCCA2 plays a role in cell cycle regulation by inducing G0/G1 arrest.
- These findings suggest HCCA2 may have a novel role in the development and progression of hepatocellular carcinoma.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...